Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activation
Atsushi SuzukiBasic Technology Research Laboratory, Daiichi Pharamceutical Co. Ltd., Tokyo R&D Center, JapanMidori HayashidaProject for the Cell Death Research, Basic Technology Research Laboratory, Daiichi Pharmaceutical Co, Ltd, Tokyo R&D Center, Kitakasai 1-16-13, Edogawa-ku, 134-8630, Tokyo, JapanTakeshi ItoThe First Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, 514-8507, Mie, JapanHirokazu KawanoProject for the Cell Death Research, Basic Technology Research Laboratory, Daiichi Pharmaceutical Co, Ltd, Tokyo R&D Center, Kitakasai 1-16-13, Edogawa-ku, 134-8630, Tokyo, JapanTakeshi NakanoThe First Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, 514-8507, Mie, JapanMasayuki MiuraDepartment of Neuroanatomy, Biomedical Research Center, Osaka University Medical School, Yamadaoka 2-2, Suita, 565, Osaka, JapanKouichi AkahaneNew Product Research Laboratories IV, Daiichi Pharmaceutical Co, Ltd, Tokyo R&D Center, Kitakasai 1-16-13, Edogawa-ku, 134-8630, Tokyo, JapanKatsuya ShirakiThe First Department of Internal Medicine, Mie University School of Medicine, Edobashi 2-174, Tsu, 514-8507, Mie, Japan
2000en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0